EA
ABBV icon

Emerald Advisors’s AbbVie ABBV Stock Holding History

Emerald Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
4,504
-2,284
-34% -$491K 0.14% 52
2026
Q1 		$1.48M Buy
6,788
+410
+6% +$90.9K 0.18% 39
2025
Q4 		$1.46M Buy
6,378
+17
+0.3% +$3.87K 0.2% 35
2025
Q3 		$1.47M Buy
6,361
+426
+7% +$86.8K 0.2% 30
2025
Q2 		$1.1M Buy
5,935
+1,543
+35% +$287K 0.14% 39
2025
Q1 		$920K Buy
4,392
+657
+18% +$128K 0.12% 42
2024
Q4 		$664K Buy
3,735
+307
+9% +$56.4K 0.09% 54
2024
Q3 		$647K Buy
3,428
+780
+29% +$146K 0.09% 54
2024
Q2 		$454K Buy
+2,648
New +$439K 0.07% 63
2020
Q1 		– Sell
-3,193
Closed -$268K – 72
2019
Q4 		$268K Buy
+3,193
New +$265K 0.26% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Emerald Advisors's ABBV Position: Q2 2026 in Review

Emerald Advisors reduced its AbbVie (ABBV) stake by 34% in Q2 2026, selling an estimated $491K and leaving 4,504 shares worth $1.13M. The position accounts for 0.14% of the portfolio, ranked #52.

Emerald Advisors first reported a position in ABBV in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.48M in Q1 2026. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Emerald Advisors held 4,504 shares of AbbVie worth $1.13M as of Q2 2026.
  • Emerald Advisors sold 2,284 AbbVie shares in Q2 2026, an estimated $491K.
  • AbbVie made up 0.14% of Emerald Advisors's portfolio in Q2 2026, its #52 holding.
  • Emerald Advisors first reported a position in AbbVie in Q4 2019 and has held it in 10 quarters since.
  • Emerald Advisors's AbbVie position peaked at $1.48M in Q1 2026.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Emerald Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.